Asia-Pacific Hospital-Acquired Infection Diagnostics Market Expected to Reach $780.882 Million by 2027

Asia-Pacific hospital-acquired infection diagnostics market accounted for $418.937 million in 2019, and is expected to reach $780.882 million by 2027, registering a CAGR of 7.5% from 2020 to 2027. Healthcare facilities in Asia-Pacific pose a unique infection risk to patients. Infections contracted during hospital stays lead to unnecessary suffering and death for millions of patients every year. Such infections are called hospital-acquired infections (HAIs), and can be defined simply as an infection contracted in a hospital environment. Furthermore, HAI are mainly caused by bacteria, viruses and fungi. Most of these diseases can be contracted anywhere, but they present greater challenges in the healthcare setting, and are costly to deal with, both financially and in terms of physical and staff resources. Hence, fuels growth of the Asia-Pacific hospital-acquired infection diagnostics market.

𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :
NG BIOTECH, DAIICHI SANKYO CO., LTD., BECTON, DICKINSON AND COMPANY, HOLOGIC, INC., ASTRAZENECA, ABBOTT LABORATORIES, SIEMENS, CEPHEID, F. HOFFMANN-LA ROCHE LTD., BIOMERIEUX SA

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/9226

On the basis of product type, the reagent and consumables segment is estimated to garner largest share during the forecast period. This segment is expected to maintain its dominant position throughout the forecast period. Growth of the segment is attributed to rise in the number of patients suffering from various infectious diseases and high prevalence of hospital acquired infections in low and middle income countries.

On the basis of test type, the molecular diagnostics segment is estimated to garner largest share during the forecast period. This is due to advantages of molecular diagnostics for infectious diseases, such as detection of lower amounts of infectious agents, provide an effective yet simple tool to establish efficacy of therapy, and modify treatment when appropriate. Furthermore, the increasing incidence of infectious diseases and the mammoth rise in reported cancer cases are fueling market growth.

On the basis of application, the surgical site infections segment is estimated to garner largest share during the forecast period. This attributed to the low awareness regarding HAIs among healthcare workers and rise in number of surgeries.

On the basis of end user, the hospital segment is estimated to garner largest share in 2019. It is expected to maintain its dominant position throughout the analysis period. Furthermore, rise in number of patients diagnosed with infectious diseases and the high probability of infections in hospital premises through blood-borne or respiratory pathogen transmission are also anticipated to boost the market growth.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/9226

India is the largest country segment of the Asia-Pacific hospital-acquired infection diagnostics market. However, the Sri Lanka and Myanmar is expected to witness significant growth in the coming years, primarily due to rising incidences of HAIs, growing number of hospitals, increasing medical tourism, and rising aging population with the resultant increase in the number of chronic disease cases, will further boost the Asia-Pacific hospital-acquired infection diagnostics market.

𝐕𝐀𝐋𝐔𝐄 𝐏𝐑𝐎𝐏𝐎𝐒𝐈𝐓𝐈𝐎𝐍𝐒 𝐑𝐄𝐋𝐀𝐓𝐄𝐃 𝐓𝐎 𝐓𝐇𝐄 𝐑𝐄𝐏𝐎𝐑𝐓:

Powered with Complimentary Analyst Hours and Expert Interviews with Each Report

Comprehensive quantitative and qualitative insights at segment and sub-segment level

Covid 19 impact trends and perspective

Granular insights at global/regional/country level

Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment

Blanket coverage on competitive landscape

Winning imperatives

Exhaustive coverage on 'Strategic Developments' registered by leading players of the market

Contact:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.